Recent studies investigating glioblastoma have shown that chemotherapy with temozolomide (TMZ) induces an upregulation of proteases such as ADAM8, ADAM10, and ADAM17, which are likely involved in the cleavage of immunomodulatory molecules like PD-L1. The gene discussed is ADAM8; the disease is glioblastoma.